1. Wimo, A, Jonsson, L, Bond, J, Prince, M, Winblad, B; Alzheimer Disease International . The worldwide economic impact of dementia 2010. Alzheimers Dement. 2013;9(1):1–11 e13.
Google Scholar | Crossref | Medline | ISI2. Kalaria, R . Similarities between Alzheimer’s disease and vascular dementia. J Neurol Sci. 2002;203-204:29–34.
Google Scholar | Crossref | Medline | ISI3. Sun, JH, Tan, L, Yu, JT. Post-stroke cognitive impairment: epidemiology, mechanisms and management. Ann Transl Med. 2014;2(8):80.
Google Scholar | Medline4. Douiri, A, Rudd, AG, Wolfe, CD. Prevalence of post stroke cognitive impairment: South London Stroke Register 1995-2010. Stroke. 2013;44(1):138–145.
Google Scholar | Crossref | Medline | ISI5. Garcia-Alloza, M, Gregory, J, Kuchibhotla, KV, et al. Cerebrovascular lesions induce transient beta-amyloid deposition. Brain. 2011;134(pt 12):3697–3707.
Google Scholar | Crossref | Medline | ISI6. Whitehead, SN, Cheng, G, Hachinski, VC, Cechetto, DF. Progressive increase in infarct size, neuroinflammation, and cognitive deficits in the presence of high levels of amyloid. Stroke. 2007;38(12):3245–3250.
Google Scholar | Crossref | Medline7. Thiel, A, Cechetto, DF, Heiss, WD, Hachinski, V, Whitehead, SN. Amyloid burden, neuroinflammation, and links to cognitive decline after ischemic stroke. Stroke. 2014;45(9):2825–2829.
Google Scholar | Crossref | Medline8. Iadecola, C, Gorelick, PB. Converging pathogenic mechanisms in vascular and neurodegenerative dementia. Stroke. 2003;34(2):335–337.
Google Scholar | Crossref | Medline9. Xiong, XY, Liu, L, Yang, QW. Functions and mechanisms of microglia/macrophages in neuroinflammation and neurogenesis after stroke. Prog Neurobiol. 2016;142:23–44.
Google Scholar | Crossref | Medline | ISI10. Stout, RD, Jiang, C, Matta, B, Tietzel, I, Watkins, SK, Suttles, J. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol. 2005;175(1):342–349.
Google Scholar | Crossref | Medline11. Gordon, S . Alternative activation of macrophages. Nat Rev Immunol. 2003;3(1):23–35.
Google Scholar | Crossref | Medline | ISI12. Liu, X, Liu, J, Zhao, S, et al. Interleukin-4 is essential for microglia/macrophage m2 polarization and long-term recovery after cerebral ischemia. Stroke. 2016;47(2):498–504.
Google Scholar | Crossref | Medline13. Uchiyama, S, Shinohara, Y, Katayama, Y, et al. Benefit of cilostazol in patients with high risk of bleeding: subanalysis of cilostazol stroke prevention study 2. Cerebrovasc Dis. 2014;37(4):296–303.
Google Scholar | Crossref | Medline14. Gresele, P, Momi, S, Falcinelli, E. Anti-platelet therapy: phosphodiesterase inhibitors. Br J Clin Pharmacol. 2011;72(4):634–646.
Google Scholar | Crossref | Medline | ISI15. Watanabe, T, Zhang, N, Liu, M, Tanaka, R, Mizuno, Y, Urabe, T. Cilostazol protects against brain white matter damage and cognitive impairment in a rat model of chronic cerebral hypoperfusion. Stroke. 2006;37(6):1539–1545.
Google Scholar | Crossref | Medline16. Saito, S, Ihara, M. New therapeutic approaches for Alzheimer’s disease and cerebral amyloid angiopathy. Front Aging Neurosci. 2014;6:290.
Google Scholar | Crossref | Medline | ISI17. Tai, SY, Chen, CH, Chien, CY, Yang, YH. Cilostazol as an add-on therapy for patients with Alzheimer’s Disease in Taiwan: a case control study. BMC Neurol. 2017;17(1):40.
Google Scholar | Crossref | Medline18. Tai, SY, Chien, CY, Chang, YH, Yang, YH. Cilostazol use is associated with reduced risk of dementia: a nationwide cohort study. Neurotherapeutics 2017;14(3):784–791.
Google Scholar | Crossref | Medline19. Sakurai, H, Hanyu, H, Sato, T, et al. Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer’s Disease and cerebrovascular disease: a pilot study. Geriatr Gerontol Int. 2013;13(1):90–97.
Google Scholar | Crossref | Medline20. Burton, EJ, Barber, R, Mukaetova-Ladinska, EB, et al. Medial temporal lobe atrophy on MRI differentiates Alzheimer’s disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis. Brain. 2009;132(pt 1):195–203.
Google Scholar | Crossref | Medline | ISI21. Nijsse, B, Visser-Meily, JM, van Mierlo, ML, Post, MW, de Kort, PL, van Heugten, CM. Temporal evolution of post stroke cognitive impairment using the Montreal cognitive assessment. Stroke. 2017;48(1):98–104.
Google Scholar | Crossref | Medline22. Wang, Q, Capistrant, BD, Ehntholt, A, Glymour, MM. Long-term rate of change in memory functioning before and after stroke onset. Stroke. 2012;43(10):2561–2566.
Google Scholar | Crossref | Medline23. Levine, DA, Galecki, AT, Langa, KM, et al. Trajectory of cognitive decline after incident stroke. JAMA. 2015;314(1):41–51.
Google Scholar | Crossref | Medline24. Makin, SD, Turpin, S, Dennis, MS, Wardlaw, JM. Cognitive impairment after lacunar stroke: systematic review and meta-analysis of incidence, prevalence and comparison with other stroke subtypes. J Neurol Neurosurg Psychiatry. 2013;84(3):893–900.
Google Scholar | Crossref | Medline25. Rafnsson, SB, Deary, IJ, Fowkes, FG. Peripheral arterial disease and cognitive function. Vasc Med. 2009;14(1):51–61.
Google Scholar | SAGE Journals | ISI26. Mangialasche, F, Solomon, A, Winblad, B, Mecocci, P, Kivipelto, M. Alzheimer’s disease: clinical trials and drug development. Lancet Neurol. 2010;9(7):702–716.
Google Scholar | Crossref | Medline | ISI27. Tilvis, RS, Kahonen-Vare, MH, Jolkkonen, J, Valvanne, J, Pitkala, KH, Strandberg, TE. Predictors of cognitive decline and mortality of aged people over a 10-year period. J Gerontol A Biol Sci Med Sci. 2004;59(3):268–274.
Google Scholar | Crossref | Medline | ISI28. Podcasy, JL, Epperson, CN. Considering sex and gender in Alzheimer disease and other dementias. Dialogues Clin Neurosci. 2016;18(4):437–446.
Google Scholar | Crossref | Medline29. Appelros, P, Stegmayr, B, Terent, A. Sex differences in stroke epidemiology: a systematic review. Stroke. 2009;40(4):1082–1090.
Google Scholar | Crossref | Medline | ISI30. Dufouil, C, Seshadri, S, Chene, G. Cardiovascular risk profile in women and dementia. J Alzheimers Dis. 2014;42(suppl 4):S353–S363.
Google Scholar | Crossref | Medline31. Pendlebury, ST, Rothwell, PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009;8(11):1006–1018.
Google Scholar | Crossref | Medline | ISI32. Glader, EL, Stegmayr, B, Norrving, B, et al. Sex differences in management and outcome after stroke: a Swedish national perspective. Stroke. 2003;34(8):1970–1975.
Google Scholar | Crossref | Medline33. Oh, H, Park, J, Seo, W. A 2-year prospective follow-up study of temporal changes associated with post-stroke cognitive impairment. Int J Nurs Pract. 2018;24(2):e12618.
Google Scholar | Crossref | Medline34. Hsieh, SW, Huang, LC, Chang, YP, Hung, CH, Yang, YH. M2b macrophage subset decrement as an indicator of cognitive function in Alzheimer’s disease. Psychiatry Clin Neurosci. 2020;74(7):383–391.
Google Scholar | Crossref | Medline35. Ganguli, M, Fu, B, Snitz, BE, et al. Vascular risk factors and cognitive decline in a population sample. Alzheimer Dis Assoc Disord. 2014;28(1):9–15.
Google Scholar | Crossref | Medline